Related Experiment Videos

Discovering fragile X syndrome: family experiences and perceptions

Donald B Bailey1, Debra Skinner, Karen L Sparkman

  • 1Frank Porter Graham Child Development Institute, University of North Carolina at Chapel Hill, 27599, USA. don_bailey@unc.edu

Pediatrics
|February 4, 2003
PubMed

Insights

Discovering fragile X syndrome (FXS) in children takes too long, with diagnosis delayed by significant developmental concerns and professional confirmation. Earlier identification of FXS is challenging but crucial for families.

Area of Science:

  • Genetics
  • Developmental Pediatrics
  • Medical Diagnostics

Background:

  • Fragile X syndrome (FXS) is a leading genetic cause of intellectual disability and autism spectrum disorder.
  • Timely diagnosis of FXS is crucial for accessing early intervention services and understanding reproductive risks.
  • Current diagnostic pathways for FXS often involve significant delays, impacting families and affected individuals.

Purpose of the Study:

  • To investigate family experiences with FXS diagnosis, including the timeline and barriers to identification.
  • To explore factors influencing the timeliness of FXS diagnosis in children.
  • To understand the perceived benefits and challenges associated with FXS diagnosis for families.

Main Methods:

  • Surveys were administered to 274 families with at least one child diagnosed with FXS.
  • Data collected included developmental concern onset, professional confirmation of delay, and FXS diagnosis age.
  • Analysis focused on identifying barriers and facilitators to timely diagnosis and perceived consequences.

Main Results:

  • For male children born in the last decade, developmental concern arose around 13 months, with diagnosis at 32 months on average.
  • Families reported significant barriers and frustration throughout the diagnostic process.
  • Some families had additional undiagnosed children with FXS, unaware of reproductive risks.

Conclusions:

  • Pediatric practices can contribute to earlier FXS identification, but limitations exist.
  • FXS and similar disorders present ongoing challenges for current newborn screening criteria.
  • Improving diagnostic timeliness requires addressing systemic barriers and enhancing screening protocols.

Related Concept Videos